SE9801474D0 - Quinoline Derivatives - Google Patents
Quinoline DerivativesInfo
- Publication number
- SE9801474D0 SE9801474D0 SE9801474A SE9801474A SE9801474D0 SE 9801474 D0 SE9801474 D0 SE 9801474D0 SE 9801474 A SE9801474 A SE 9801474A SE 9801474 A SE9801474 A SE 9801474A SE 9801474 D0 SE9801474 D0 SE 9801474D0
- Authority
- SE
- Sweden
- Prior art keywords
- propyl
- iso
- butyl
- formula
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Priority Applications (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801474A SE9801474D0 (sv) | 1998-04-27 | 1998-04-27 | Quinoline Derivatives |
US09/296,519 US6077851A (en) | 1998-04-27 | 1999-04-22 | Quinoline derivatives |
TR2000/03061T TR200003061T2 (tr) | 1998-04-27 | 1999-04-26 | Kinolin türevleri |
IDW20002183A ID26277A (id) | 1998-04-27 | 1999-04-26 | Turunan-turunan kuinolina |
MEP-2000-612A ME00870B (me) | 1998-04-27 | 1999-04-26 | Derivati hinolina |
OA1200000301A OA11547A (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives. |
PCT/SE1999/000676 WO1999055678A1 (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives |
BRPI9909925-0A BR9909925B1 (pt) | 1998-04-27 | 1999-04-26 | derivados de quinolina, composições farmacêuticas, e, processo para a fabricação de derivados de quinolina. |
EEP200000613A EE04275B1 (et) | 1998-04-27 | 1999-04-26 | Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid |
HU0102084A HU227709B1 (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives, process for producing them and pharmaceutical compositions containing them |
KR1020007011944A KR100571534B1 (ko) | 1998-04-27 | 1999-04-26 | 퀴놀린 유도체 |
PL99343420A PL190441B1 (pl) | 1998-04-27 | 1999-04-26 | Nowe pochodne 1-metylo-2-okso-chinolino-3-karboksyamidu zawierające je kompozycje farmaceutyczne oraz sposób ich wytwarzania |
UA2000085078A UA60354C2 (uk) | 1998-04-27 | 1999-04-26 | Похідні хіноліну, спосіб їх одержання (варіанти) та спосіб лікування ссавців |
IL13816099A IL138160A0 (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives |
RU2000129672/04A RU2197481C2 (ru) | 1998-04-27 | 1999-04-26 | Производные хинолина |
JP2000545838A JP4045069B2 (ja) | 1998-04-27 | 1999-04-26 | キノリン誘導体 |
AT99947036T ATE228505T1 (de) | 1998-04-27 | 1999-04-26 | Chinolinderivate |
NZ506641A NZ506641A (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives useful in the treatment of autoimmune disorders |
CA002329788A CA2329788C (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives |
CZ20003849A CZ297439B6 (cs) | 1998-04-27 | 1999-04-26 | Deriváty chinolinu |
EP99947036A EP1073639B1 (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives |
ES99947036T ES2188242T3 (es) | 1998-04-27 | 1999-04-26 | Derivados de quinolina. |
YUP-612/00A RS50029B (sr) | 1998-04-27 | 1999-04-26 | Derivati hinolina |
CN99805581A CN1113057C (zh) | 1998-04-27 | 1999-04-26 | 喹啉衍生物 |
DK99947036T DK1073639T3 (da) | 1998-04-27 | 1999-04-26 | Chinolinderivater |
PT99947036T PT1073639E (pt) | 1998-04-27 | 1999-04-26 | Derivados de quinolina |
AU43013/99A AU747550B2 (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives |
APAP/P/2000/001933A AP1293A (en) | 1998-04-27 | 1999-04-26 | Quinoline derivatives. |
DE69904162T DE69904162T2 (de) | 1998-04-27 | 1999-04-26 | Chinolinderivate |
IL138160A IL138160A (en) | 1998-04-27 | 2000-08-30 | Quinoline derivatives |
IS5615A IS2082B (is) | 1998-04-27 | 2000-08-31 | Kvínólínafleiður |
ZA200004601A ZA200004601B (en) | 1998-04-27 | 2000-09-01 | Quinoline derivatives. |
NO20005254A NO315606B1 (no) | 1998-04-27 | 2000-10-19 | Kinolinderivater |
HR20000726A HRP20000726B1 (en) | 1998-04-27 | 2000-10-26 | Quinoline derivatives |
HK01105489A HK1036618A1 (en) | 1998-04-27 | 2001-08-07 | Quinoline derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801474A SE9801474D0 (sv) | 1998-04-27 | 1998-04-27 | Quinoline Derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9801474D0 true SE9801474D0 (sv) | 1998-04-27 |
Family
ID=20411103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9801474A SE9801474D0 (sv) | 1998-04-27 | 1998-04-27 | Quinoline Derivatives |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP1073639B1 (sv) |
JP (1) | JP4045069B2 (sv) |
KR (1) | KR100571534B1 (sv) |
CN (1) | CN1113057C (sv) |
AP (1) | AP1293A (sv) |
AT (1) | ATE228505T1 (sv) |
AU (1) | AU747550B2 (sv) |
BR (1) | BR9909925B1 (sv) |
CA (1) | CA2329788C (sv) |
CZ (1) | CZ297439B6 (sv) |
DE (1) | DE69904162T2 (sv) |
DK (1) | DK1073639T3 (sv) |
EE (1) | EE04275B1 (sv) |
ES (1) | ES2188242T3 (sv) |
HK (1) | HK1036618A1 (sv) |
HR (1) | HRP20000726B1 (sv) |
HU (1) | HU227709B1 (sv) |
ID (1) | ID26277A (sv) |
IL (2) | IL138160A0 (sv) |
IS (1) | IS2082B (sv) |
ME (1) | ME00870B (sv) |
NO (1) | NO315606B1 (sv) |
NZ (1) | NZ506641A (sv) |
OA (1) | OA11547A (sv) |
PL (1) | PL190441B1 (sv) |
PT (1) | PT1073639E (sv) |
RS (1) | RS50029B (sv) |
RU (1) | RU2197481C2 (sv) |
SE (1) | SE9801474D0 (sv) |
TR (1) | TR200003061T2 (sv) |
UA (1) | UA60354C2 (sv) |
WO (1) | WO1999055678A1 (sv) |
ZA (1) | ZA200004601B (sv) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0002320D0 (sv) * | 1999-10-25 | 2000-06-21 | Active Biotech Ab | Malignant tumors |
SE0201778D0 (sv) * | 2002-06-12 | 2002-06-12 | Active Biotech Ab | Process for the manufacture of quinoline derivatives |
KR100908655B1 (ko) | 2002-11-27 | 2009-07-21 | 엘지디스플레이 주식회사 | 데이터 공급시간의 변조방법과 이를 이용한액정표시장치의 구동방법 및 장치 |
SE0400235D0 (sv) * | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New composition containing quinoline compounds |
SE0401578D0 (sv) * | 2004-06-18 | 2004-06-18 | Active Biotech Ab | Novel compounds |
US7838522B2 (en) | 2004-11-17 | 2010-11-23 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
CN101124213B (zh) | 2004-12-21 | 2012-02-01 | 默克雪兰诺有限公司 | 磺酰氨基环状衍生物及其应用 |
CA2592154C (en) | 2005-01-31 | 2014-03-18 | Laboratoires Serono S.A. | N-hydroxyamide derivatives and use thereof |
KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 jnk 억제제 |
BRPI0613042A2 (pt) | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
AU2006286489B2 (en) | 2005-09-01 | 2012-08-09 | Ares Trading S.A. | Treatment of optic neuritis |
CN103333107A (zh) * | 2005-10-19 | 2013-10-02 | 泰华制药工业有限公司 | 拉奎尼莫钠晶体及其制备方法 |
AR061348A1 (es) | 2006-06-12 | 2008-08-20 | Teva Pharma | Preparados estables de laquinimod |
EP2234485B1 (en) | 2007-12-20 | 2013-11-13 | Teva Pharmaceutical Industries, Ltd. | Stable laquinimod preparations |
JP2012502038A (ja) * | 2008-09-03 | 2012-01-26 | テバ ファーマシューティカル インダストリーズ リミティド | 免疫機能の2−オキソ−1,2−ジヒドロ−キノリンモジュレーター |
DK2458992T3 (en) * | 2009-07-30 | 2016-02-08 | Teva Pharma | Treatment of crohn's disease with laquinimod |
PT2467372T (pt) | 2009-08-10 | 2016-08-23 | Teva Pharma | Tratamento de distúrbios relacionados com bdnf usando laquinimod |
JP2013521305A (ja) * | 2010-03-03 | 2013-06-10 | テバ ファーマシューティカル インダストリーズ リミティド | ラキニモドを用いるループス関節炎の治療 |
WO2011109526A1 (en) * | 2010-03-03 | 2011-09-09 | Teva Pharmaceutical Industries Ltd. | Treatment of lupus nephritis using laquinimod |
US8501766B2 (en) | 2010-03-03 | 2013-08-06 | Teva Pharmaceutical Industries Ltd. | Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate |
WO2011116091A1 (en) | 2010-03-17 | 2011-09-22 | Novartis Ag | Dispenser |
CA2804986A1 (en) | 2010-07-09 | 2012-01-12 | Teva Pharmaceutical Industries Ltd. | Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
WO2012004338A1 (en) * | 2010-07-09 | 2012-01-12 | Active Biotech Ab | Method for manufacturing of quinoline-3-carboxamides |
NZ606589A (en) * | 2010-07-09 | 2015-03-27 | Teva Pharma | 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof |
EP2444086A1 (en) | 2010-10-22 | 2012-04-25 | Almirall, S.A. | Combinations comprising DHODH inhibitors and COX inhibitors |
AU2012322706A1 (en) | 2011-10-12 | 2014-05-22 | Teva Pharmaceutical Industries Ltd. | Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
EA201491460A1 (ru) * | 2012-02-03 | 2015-01-30 | Тева Фармасьютикал Индастриз Лтд. | ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα |
US9284276B2 (en) | 2012-02-16 | 2016-03-15 | Teva Pharmaceutical Industries, Ltd. | N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof |
TW201350467A (zh) | 2012-05-08 | 2013-12-16 | Teva Pharma | N-乙基-4-羥基-1-甲基-5-(甲基(2,3,4,5,6-五羥基己基)胺基)-2-側氧-n-苯基-1,2-二氫喹啉-3-甲醯胺 |
TW201400117A (zh) | 2012-06-05 | 2014-01-01 | Teva Pharma | 使用拉喹莫德治療眼發炎疾病 |
TW201410244A (zh) | 2012-08-13 | 2014-03-16 | Teva Pharma | 用於治療gaba媒介之疾病之拉喹莫德(laquinimod) |
AU2013341506A1 (en) | 2012-11-07 | 2015-06-04 | Teva Pharmaceutical Industries Ltd. | Amine salts of Laquinimod |
RU2545056C2 (ru) * | 2012-12-10 | 2015-03-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия" Министерства здавоохранения и социального развития Российской Федерации (ГБОУ ВПО ПГФА Минздравсоцразвития России) | Противовоспалительное и анальгетическое средство на основе изопропиламида 1,2-дигидро-1н-2-оксоцинхониновой кислоты |
WO2014127139A1 (en) * | 2013-02-15 | 2014-08-21 | Teva Pharmaceutical Industries Ltd. | Treatment of multiple sclerosis with laquinimod |
AU2014236232A1 (en) | 2013-03-14 | 2015-11-05 | Teva Pharmaceutical Industries Ltd. | Crystals of laquinimod sodium and improved process for the manufacture thereof |
WO2015168103A1 (en) | 2014-04-29 | 2015-11-05 | Teva Pharmaceutical Industries Ltd. | Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability status |
KR102533033B1 (ko) | 2014-09-23 | 2023-05-15 | 액티브 바이오테크 에이비 | 다발성 골수종의 치료에 사용하기 위한 퀴놀린 카르복사미드 |
AU2015348778B2 (en) | 2014-11-19 | 2020-12-24 | Active Biotech Ab | Quinoline carboxamides for use in the treatment of leukemia |
IL293469B2 (en) | 2019-12-19 | 2024-04-01 | Active Biotech Ab | Compounds for the treatment of eye diseases are associated with increased blood vessel formation |
IL295780A (en) | 2020-03-03 | 2022-10-01 | Active Biotech Ab | Tesquinimov or a pharmaceutically acceptable salt thereof for use in combination therapy |
KR20230043916A (ko) | 2020-07-23 | 2023-03-31 | 에라스무스 유니버시티 메디컬 센터 로테르담 | 골수증식성 신생물의 새로운 치료학적 표적으로서 s100 단백질 |
CA3204120A1 (en) | 2021-01-18 | 2022-07-21 | Active Biotech Ab | Tasquinimod or a pharmaceutically acceptable salt thereof for use in the treatment of myelodysplastic syndrome |
BR112023023715A2 (pt) | 2021-05-25 | 2024-02-20 | Active Biotech Ab | Pluralidade de partículas compreendendo tasquinimod, composição farmacêutica, unidade de dosagem farmacêutica, uso da pluralidade de partículas ou da composição farmacêutica, e, método para o tratamento do câncer |
CA3221689A1 (en) | 2021-07-02 | 2023-01-05 | Hans Wannman | A pharmaceutical product containing tasquinimod and a method for assessing the purity of said product |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
GB9108547D0 (en) * | 1991-04-22 | 1991-06-05 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
-
1998
- 1998-04-27 SE SE9801474A patent/SE9801474D0/sv unknown
-
1999
- 1999-04-26 EP EP99947036A patent/EP1073639B1/en not_active Expired - Lifetime
- 1999-04-26 JP JP2000545838A patent/JP4045069B2/ja not_active Expired - Lifetime
- 1999-04-26 ME MEP-2000-612A patent/ME00870B/me unknown
- 1999-04-26 RU RU2000129672/04A patent/RU2197481C2/ru not_active IP Right Cessation
- 1999-04-26 DE DE69904162T patent/DE69904162T2/de not_active Expired - Lifetime
- 1999-04-26 RS YUP-612/00A patent/RS50029B/sr unknown
- 1999-04-26 AU AU43013/99A patent/AU747550B2/en not_active Ceased
- 1999-04-26 NZ NZ506641A patent/NZ506641A/en not_active IP Right Cessation
- 1999-04-26 TR TR2000/03061T patent/TR200003061T2/xx unknown
- 1999-04-26 EE EEP200000613A patent/EE04275B1/xx unknown
- 1999-04-26 WO PCT/SE1999/000676 patent/WO1999055678A1/en active IP Right Grant
- 1999-04-26 ID IDW20002183A patent/ID26277A/id unknown
- 1999-04-26 AT AT99947036T patent/ATE228505T1/de active
- 1999-04-26 DK DK99947036T patent/DK1073639T3/da active
- 1999-04-26 PT PT99947036T patent/PT1073639E/pt unknown
- 1999-04-26 UA UA2000085078A patent/UA60354C2/uk unknown
- 1999-04-26 IL IL13816099A patent/IL138160A0/xx active IP Right Grant
- 1999-04-26 BR BRPI9909925-0A patent/BR9909925B1/pt not_active IP Right Cessation
- 1999-04-26 CA CA002329788A patent/CA2329788C/en not_active Expired - Fee Related
- 1999-04-26 ES ES99947036T patent/ES2188242T3/es not_active Expired - Lifetime
- 1999-04-26 OA OA1200000301A patent/OA11547A/en unknown
- 1999-04-26 PL PL99343420A patent/PL190441B1/pl unknown
- 1999-04-26 CN CN99805581A patent/CN1113057C/zh not_active Expired - Fee Related
- 1999-04-26 AP APAP/P/2000/001933A patent/AP1293A/en active
- 1999-04-26 KR KR1020007011944A patent/KR100571534B1/ko not_active IP Right Cessation
- 1999-04-26 HU HU0102084A patent/HU227709B1/hu not_active IP Right Cessation
- 1999-04-26 CZ CZ20003849A patent/CZ297439B6/cs not_active IP Right Cessation
-
2000
- 2000-08-30 IL IL138160A patent/IL138160A/en not_active IP Right Cessation
- 2000-08-31 IS IS5615A patent/IS2082B/is unknown
- 2000-09-01 ZA ZA200004601A patent/ZA200004601B/en unknown
- 2000-10-19 NO NO20005254A patent/NO315606B1/no not_active IP Right Cessation
- 2000-10-26 HR HR20000726A patent/HRP20000726B1/xx not_active IP Right Cessation
-
2001
- 2001-08-07 HK HK01105489A patent/HK1036618A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9801474D0 (sv) | Quinoline Derivatives | |
SE9802549D0 (sv) | Quinoline derivatives | |
WO2003080580A3 (en) | Quinoline derivatives and their use as 5-ht6 ligands | |
AP1425A (en) | Quinoline derivatives. | |
ATE37179T1 (de) | Dihydropyridazinone. | |
EA200100553A1 (ru) | Замещенные бициклические производные, полезные в качестве противораковых агентов | |
ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
EE200100513A (et) | Rakkude adhesiooni inhibeerivad põletikuvastased ja immunosupressiivsed ühendid | |
ATE227293T1 (de) | 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one | |
AR002711A1 (es) | Un compuesto de 2-carboxindol-3-substituido,un proceso para su preparacion, un nuevo compuesto intermediario para dicho proceso, el uso del compuesto parala fabricacion de un agente terapeutico y una composicion farmaceutica que comprende dicho compuesto. | |
FI955085A (sv) | Nya diosmetinföreningar, förfarande för deras framställning och farmaceutiska kompositioner som innehåller dessa föreningar | |
EA200101050A1 (ru) | Замещенные бензолактамные соединения | |
NO833918L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolderivater | |
SE0400440D0 (sv) | Novel Cinnamic Amides | |
ATE264320T1 (de) | 5-aminoalkyl- und 5-aminocarbonylsubstituierte indole | |
FI834789A0 (fi) | Foerfarande foer framstaellning av 1,1-difenylpropanolderivat | |
SE8405332L (sv) | 2h-azeto (2,1-a)-isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem | |
SE9902147L (sv) | Nya föreningar och farmaceutiska kompositioner innehållande desamma |